As ERBB2+ BC cells heavily depend on ERBB2 receptor signaling for their growth and survival, and because CHD4 depletion inhibits BC tumor development in the MMTV/NeuT model, we hypothesized that CHD4 silencing might impair the ERBB2 signaling pathway. Here, CHD4 is linked to neoplasm.